Concepedia

Kha Le

KL

Statistics

Publications

20

Citations

1.7K

H-Index

15

Active since

1999

Affiliations

Agios Pharmaceuticals (United States)(Current)

Massachusetts General Hospital

The University of Texas Southwestern Medical Center

Memorial Sloan Kettering Cancer Center

University of California, San Francisco

Kha Le is an author at Agios Pharmaceuticals (United States) specializing in medicine, pharmacology, and glioma.

ORCID

Top concepts

Publications per year

1999–2023

20

Publications

20

Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD

Robert L. Avery, Alessandro Castellarin, Nathan Steinle et al. · British Journal of Ophthalmology · 2014 · 362 citations · Full text

SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB

Robert L. Avery, Alessandro Castellarin, Nathan Steinle et al. · Retina · 2017 · 318 citations · Full text

Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial

Ingo K. Mellinghoff, Marta Peñas-Prado, Katherine B. Peters et al. · Clinical Cancer Research · 2021 · 234 citations · Full text

Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial

Ingo K. Mellinghoff, Min Lu, Patrick Y. Wen et al. · Nature Medicine · 2023 · 191 citations · Full text

Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration

Brian L. Yaspan, David F. Williams, Frank G. Holz et al. · Science Translational Medicine · 2017 · 178 citations

, , +12

Rows per page

1–5 of 20